Beese Fulmer Investment Management, Inc. Pfizer Inc Transaction History

Beese Fulmer Investment Management, Inc.

$1.3 Billion
Q2 2025

A detailed history of Beese Fulmer Investment Management, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Beese Fulmer Investment Management, Inc. holds 100,404 shares of PFE stock, worth $2.5 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

100,404

Previous 59,050 70.03%

Holding current value

$2.5 Million

Previous $1.5 Million 62.63%

% of portfolio

0.19%

Previous 0.13%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 07, 2025	BUY	$21.59 - $24.84 $892,832 - $1.03 Million	41,354 Added 70.03%	100,404 $2.43 Million
Q1 2025 Apr 08, 2025	BUY	$25.01 - $27.13 $180,847 - $196,177	7,231 Added 13.95%	59,050 $1.5 Million
Q4 2024 Jan 28, 2025	SELL	$24.8 - $30.19 $80,525 - $98,026	-3,247 Reduced 5.9%	51,819 $1.37 Million
Q3 2024 Oct 22, 2024	SELL	$27.7 - $31.39 $6,038 - $6,843	-218 Reduced 0.39%	55,066 $1.59 Million
Q2 2024 Jul 03, 2024	SELL	$25.26 - $29.6 $110,941 - $130,003	-4,392 Reduced 7.36%	55,284 $1.55 Million
Q1 2024 Apr 08, 2024	SELL	$25.89 - $29.73 $162,718 - $186,853	-6,285 Reduced 9.53%	59,676 $1.66 Million
Q4 2023 Jan 09, 2024	SELL	$26.13 - $33.94 $159,732 - $207,475	-6,113 Reduced 8.48%	65,961 $1.9 Million
Q3 2023 Oct 10, 2023	SELL	$32.09 - $37.51 $33,919 - $39,648	-1,057 Reduced 1.45%	72,074 $2.39 Million
Q2 2023 Jul 11, 2023	SELL	$36.12 - $41.79 $99,257 - $114,838	-2,748 Reduced 3.62%	73,131 $2.68 Million
Q1 2023 Apr 11, 2023	SELL	$39.39 - $51.28 $90,715 - $118,097	-2,303 Reduced 2.95%	75,879 $3.1 Million
Q4 2022 Jan 17, 2023	SELL	$41.75 - $54.5 $6,053 - $7,902	-145 Reduced 0.19%	78,182 $0
Q3 2022 Oct 06, 2022	BUY	$43.76 - $53.42 $51,986 - $63,462	1,188 Added 1.54%	78,327 $3.43 Million
Q2 2022 Jul 11, 2022	BUY	$46.53 - $55.17 $3,070 - $3,641	66 Added 0.09%	77,139 $4.04 Million
Q1 2022 Apr 12, 2022	SELL	$45.75 - $56.69 $223,397 - $276,817	-4,883 Reduced 5.96%	77,073 $3.99 Million
Q4 2021 Jan 10, 2022	SELL	$41.32 - $61.25 $45,865 - $67,987	-1,110 Reduced 1.34%	81,956 $4.84 Million
Q3 2021 Oct 08, 2021	SELL	$39.25 - $50.42 $23,707 - $30,453	-604 Reduced 0.72%	83,066 $3.57 Million
Q2 2021 Jul 08, 2021	BUY	$35.91 - $40.68 $11,778 - $13,343	328 Added 0.39%	83,670 $3.28 Million
Q1 2021 Apr 23, 2021	BUY	$33.49 - $37.77 $29,069 - $32,784	868 Added 1.05%	83,342 $3.02 Million
Q4 2020 Jan 20, 2021	BUY	$33.47 - $42.56 $25,303 - $32,175	756 Added 0.93%	82,474 $3.04 Million
Q3 2020 Oct 08, 2020	SELL	$31.75 - $37.25 $169,576 - $198,952	-5,341 Reduced 6.13%	81,718 $3 Million
Q2 2020 Jul 17, 2020	SELL	$30.12 - $36.54 $24,126 - $29,268	-801 Reduced 0.91%	87,059 $2.85 Million
Q1 2020 Apr 09, 2020	SELL	$27.03 - $38.62 $39,490 - $56,423	-1,461 Reduced 1.64%	87,860 $2.87 Million
Q4 2019 Feb 05, 2020	SELL	$32.92 - $37.36 $158,180 - $179,514	-4,805 Reduced 5.1%	89,321 $3.5 Million
Q3 2019 Nov 01, 2019	BUY	$32.49 - $42.13 $1.15 Million - $1.5 Million	35,488 Added 60.52%	94,126 $3.38 Million
Q4 2018 Jan 25, 2019	SELL	$38.47 - $43.86 $11,541 - $13,158	-300 Reduced 0.51%	58,638 $2.56 Million
Q3 2018 Oct 09, 2018	BUY	$34.47 - $41.81 $10,341 - $12,543	300 Added 0.51%	58,938 $2.6 Million
Q1 2018 Apr 16, 2018	SELL	$31.91 - $37.02 $15,380 - $17,843	-482 Reduced 0.82%	58,638 $2.08 Million
Q4 2017 Jan 26, 2018	SELL	$33.26 - $35.29 $56,874 - $60,345	-1,710 Reduced 2.81%	59,120 $2.14 Million
Q3 2017 Oct 17, 2017	BUY	$31.0 - $34.15 $1.89 Million - $2.08 Million	60,830	60,830 $2.17 Million

Others Institutions Holding PFE

# of Institutions

3,327

Shares Held

3.64B

Call Options Held

103M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $139B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Beese Fulmer Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Beese Fulmer Investment Management, Inc. with notifications on news.

Account

Beese Fulmer Investment Management, Inc. Pfizer Inc Transaction History